Read Financial Articles on Day Trading, Investment, Stock Market, NIFTY, BSE, NSE, Mutual Fund, Commodities and ETF
JACKPOT PACKAGE: Get 95%+ Accuracy in our premium package. Charges only Rs.5000/Month.
To Get Free Trial Just SMS JACKPOT and your Name to 9999961207 or Call Us.
Share Gyan launches new website for COMMODITY TIPS. Register for free trial @ CommodityGyan.in now!


News Tagged as ‘Aurobindo Pharma’

Aurobindo bags three goods sanction

Thursday, March 19, 2009 12:41 pm No Comments

A Hyderabad-based producer of general pharmaceuticals and dynamic pharmaceutical constituents, Aurobindo Pharma Limited has got registrations from the Medicines Control Council to produce and advertise 3 goods in South Africa.

By ShareGyan.com NewsDesk Tags: ,

Pfizer gets bigger with Aurobindo agreement

Wednesday, March 4, 2009 10:05 am No Comments

Pfizer has moved ahead to enlarge the pact with Aurobindo to 44 drugs now.

By ShareGyan.com NewsDesk Tags: , ,

Aurobindo bags anti-epilepsy drug approval

Friday, January 16, 2009 1:00 pm No Comments

A Hyderabad-based manufacturer of generic pharmaceuticals and active pharmaceutical ingredients (APIs), Aurobindo Pharma Ltd has bagged final sanctions from the US Food and Drug Administration (US FDA) for Levetiracetam tablets in 250 mg, 500mg, 750 mg and 1000mg strengths and Levetiracetam oral solution in 100mg/ml form.

By ShareGyan.com NewsDesk Tags: ,

Aurobindo Pharma receives USFDA nod for 2 drugs

Wednesday, December 31, 2008 3:34 pm No Comments

Aurobindo Pharma, drug maker today said it has got approvals from US drug regulator for Stavudine capsules and Stavudine oral solution, which are used in the treatment of HIV-1 infection.

By ShareGyan.com NewsDesk Tags: , , ,

Aurobindo Pharma gets Canada approval

Wednesday, December 24, 2008 2:38 pm No Comments

Aurobindo Pharma has gone up by over 3% to Rs155

By ShareGyan.com NewsDesk Tags: , , ,

Aurobindo Pharma bags tentative sanction for its New Drug Application

Monday, December 22, 2008 2:15 pm No Comments

Aurobindo Pharma has got the provisional sanction to produce and market fixed dosed combination Abacavir Sulfate / Lamivudine Tablets 60/30 mg from the US Food & Drug Administration (USFDA), the company said in a press release provided to BSE.

By ShareGyan.com NewsDesk Tags: ,

Copyright © 2009 ShareGyan.com. All rights reserved.

Disclaimer: Trading or investing in stocks & commodities is a high risk activity. Any action you choose to take in the markets is totally your own responsibility. ShareGyan.com will not be liable for any, direct or indirect, consequential or incidental damages or loss arising out of the use of this information.

Disclosure: The information on this website is neither an offer to sell nor solicitation to buy any of the securities mentioned herein. The writers may or may not be trading in the securities mentioned.